TY - JOUR
T1 - Consortium biology in immunology
T2 - The perspective from the Immunological Genome Project
AU - The Immunological Genome Project Consortium
AU - Benoist, Christophe
AU - Lanier, Lewis
AU - Merad, Miriam
AU - Mathis, Diane
AU - Ericson, Jeff
AU - Painter, Michio
AU - Davis, Scott
AU - Laplace, Catherine
AU - Hyatt, Gordon
AU - Paik, Henry
AU - Rothamel, Katie
AU - Cruse, Richard
AU - Doran, Graeme
AU - Heng, Tracy
AU - Asinovski, Natasha
AU - Ortiz-Lopes, Adriana
AU - Ergun, Ayla
AU - Gray, Daniel
AU - Wakamatsu, Ei
AU - Hill, Jonathan
AU - Mingueneau, Michael
AU - Cipolletta, Daniela
AU - Yoshida, Hideyuki
AU - Cohen, Nadia
AU - Kim, Edy
AU - Brennan, Patrick
AU - Lynch, Lydia
AU - Brenner, Michael
AU - Costello, James
AU - Collins, Jim J.
AU - Blair, David
AU - Dustin, Michael
AU - Knell, Jamie
AU - Yang, Edward
AU - Best, Adam
AU - Shaw, Laura
AU - Doedens, Andrew
AU - Goldrath, Ananda
AU - Shinton, Susan
AU - Zhou, Yan
AU - Hardy, Randy
AU - Jojic, Vladimir
AU - Mostafavi, Sara
AU - Koller, Daphne
AU - Jianu, Radu
AU - Laidlaw, David
AU - Bezman, Natalie
AU - Sun, Joseph
AU - Shay, Tal
AU - Gazit, Roi
N1 - Funding Information:
We thank R. Germain, B. Malissen and the reviewers for com‑ ments and suggestions. The ImmGen programme is sup‑ ported by grant R24‑AI072073 from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, and is grateful to eBioscience, Affymetrix and Expression Analysis for sponsorship.
Funding Information:
M.R. is supported by the European Research Council, the European Commission (FP7: IBDase, MetaHIT), the Italian Ministry of Health, the Association for International Cancer Research and the Italian Association for Cancer Research.
Funding Information:
8 European laboratories supported by the EU
PY - 2012/10/1
Y1 - 2012/10/1
N2 - Although the field has a long collaborative tradition, immunology has made less use than genetics of 'consortium biology', wherein groups of investigators together tackle large integrated questions or problems. However, immunology is naturally suited to large-scale integrative and systems-level approaches, owing to the multicellular and adaptive nature of the cells it encompasses. Here, we discuss the value and drawbacks of this organization of research, in the context of the long-running 'big science' debate, and consider the opportunities that may exist for the immunology community. We position this analysis in light of our own experience, both positive and negative, as participants of the Immunological Genome Project.
AB - Although the field has a long collaborative tradition, immunology has made less use than genetics of 'consortium biology', wherein groups of investigators together tackle large integrated questions or problems. However, immunology is naturally suited to large-scale integrative and systems-level approaches, owing to the multicellular and adaptive nature of the cells it encompasses. Here, we discuss the value and drawbacks of this organization of research, in the context of the long-running 'big science' debate, and consider the opportunities that may exist for the immunology community. We position this analysis in light of our own experience, both positive and negative, as participants of the Immunological Genome Project.
UR - http://www.scopus.com/inward/record.url?scp=84866728729&partnerID=8YFLogxK
U2 - 10.1038/nri3300
DO - 10.1038/nri3300
M3 - Review article
C2 - 22955842
AN - SCOPUS:84866728729
SN - 1474-1733
VL - 12
SP - 734
EP - 740
JO - Nature Reviews Immunology
JF - Nature Reviews Immunology
IS - 10
ER -